Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Conjunctivitis

Conjunctivitis

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Conjunctivitis

14 trials tracked for Conjunctivitis: 9 in phase 3 or 4.

14Trials tracked
9Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 2 Phase 3 7 Phase 2 2 Phase 1 1 Other / NA 2
  1. Phase 4 Moxifloxacin vs. Polytrim for Conjunctivitis Completed
  2. Phase 4 Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis Completed
  3. Phase 3 Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis Completed
  4. Phase 3 Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234) Completed
  5. Phase 3 Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) Completed
  6. Phase 3 Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis Completed
Show 8 more trials
  1. Phase 3 A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067) Completed
  2. Phase 3 Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) Completed
  3. Phase 3 Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED) Completed
  4. Phase 2 Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conjunctivitis Symptoms and Skin Test Reactivity Upon Exposure to Birch Allergen in Adult Participants Completed
  5. Phase 2 Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081) Completed
  6. Phase 1 Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects Completed
  7. N/A A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis Completed
  8. N/A Reducing Adenoviral Patient Infected Days Completed

Showing the 14 most-cited and recently-updated of 14 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Ocular morbidity prevalence of 43.1% among incarcerated populations in sub-Saharan Africa
Ophthalmology Meta-analysis
Ocular morbidity prevalence of 43.1% among incarcerated populations in sub-Saharan Africa Factors Linked to Eye Conditions in Sub-Saharan African Prisons
This meta-analysis of 3,361 individuals in sub-Saharan African prisons identifies a 43.1% prevalence of ocular morbidity. Key associated fac…
A study of over 3,000 people in African prisons found that age, past injuries, and length of stay are linked to common eye conditions.
Frontiers Oct 24, 2026